ExLibris header image
SFX Logo
Title: A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Source:

Ebiomedicine [2352-3964] Hoyer, K yr:2021


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO

Expand list of advanced services Advanced